Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Double-blinded, Randomised Study to Evaluate the Effects of Different Doses of Statin Treatment on Plaque Volume and Composition in Coronary Disease Determined by Virtual Histology Using Intravascular Ultrasound

Next Previous
Search
Trial Profile

A Prospective, Double-blinded, Randomised Study to Evaluate the Effects of Different Doses of Statin Treatment on Plaque Volume and Composition in Coronary Disease Determined by Virtual Histology Using Intravascular Ultrasound

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Mar 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Angina pectoris; Atherosclerosis; Coronary artery disease
  • Focus Pharmacodynamics
  • Acronyms VENUS

    • Most Recent Events

    • 07 Nov 2012 Results reporting effects of atorvastatin on endothelial progenitor cells, cardiac events, C-reactive protein levels and intima-media thickness presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 02 Aug 2012 Results published in the Circulation Journal.
    • 02 Aug 2012 Primary endpoint 'Ultrasound-imaging-outcomes' has been met.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top